Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-opioid anesthesia with esketamine in breast cancer surgery
ChiCTR2200061136Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Anhui Medical University
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in breast cancer (3 arms), sponsored by The Second Affiliated Hospital of Anhui Medical University. Primary endpoints: Intraoperative sufentanil dosage and Dosage of postoperative analgesics. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR2200061136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061136.